HANGZHOU, China, Dec. 5, 2017 /PRNewswire/ -- China Jo-Jo
Drugstores, Inc. (NASDAQ: CJJD)
(the "Company" or "China Jo-Jo") has opened seven new retail
drugstores in the city of Hangzhou.
"China Jo-Jo is pleased to further consolidate our retail
pharmacy leadership in the Hangzhou community, offering convenient access
to best-in-class pharmacy products and services," said Liu Lei, Chairman and CEO of China Jo-Jo
Drugstores. "I look forward to these new stores serving as
destination for health and wellbeing that offer our customers an
excellent and reliable experience."
China Jo-Jo's new stores feature products and services for which
thousands of customers across Hangzhou visit its stores every day,
including:
- A full service pharmacy staffed by licensed pharmacists and
pharmacy staff
- Prescription and OTC medicines, Traditional Chinese Medicines,
dietary supplements, medical devices
- Health and beauty products including many popular brands
- General merchandise
- The China Jo-Jo Rewards Program, which offers exclusive
discounts and enhance customer experience
The seven new China Jo-Jo stores are located at:
- No. 134 Wangshang Road, Binjiang District
- No. 7-7-10 Zhuantang Jiayuan,
Binjiang District
- No. 440, 442, Fenghuangshan Road, Yuhang District
- No. 6, 7-129, Yunzhong Lvyuan, Lin'an District
- No. 403, Qianwang Street, Lin'an District
- No. 72, Caidong Road, Jianggan District
- No 348-103, Qingtai Street, Shangcheng District
About China Jo-Jo Drugstores, Inc.
China Jo-Jo Drugstores, Inc., is a leading China-based pharmacy that engages in retail,
wholesale and online sales and distribution of pharmaceutical and
health care products, including through its online and retail
pharmacies. As of December 05, 2017,
the Company had 108 retail pharmacies in Zhejiang Province. The Company's wholesale
subsidiary supplies its retail stores and distributes drug and
healthcare products to other drugstores and drug vendors. For more
information, visit: www.chinajojodrugstores.com.
Forward Looking
Statement
Statements in this press release regarding the Company that are
not historical facts are forward-looking statements and are subject
to risks and uncertainties that could cause actual future events or
results to differ materially from such statements. Any such
forward-looking statements, including, but not limited to,
financial guidance, are made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. These
statements can be identified by the use of forward-looking
terminology such as "believe," "expect," "estimate," "may," "will,"
"should," "project," "plan," "seek," "intend," "anticipate," the
negatives thereof, or comparable terminology. Such statements
typically involve risks and uncertainties and may include financial
projections or information regarding the progress of new product
development. It is routine for the Company's internal projections
and expectations to change as the quarter and year progresses, and
therefore it should be clearly understood that the internal
projections and beliefs upon which the Company bases its
expectations may change. Although these expectations may change,
the Company is under no obligation to inform you if they do. Actual
results could differ materially from the expectations reflected in
such forward-looking statements as a result of numerous factors,
including the risks associated with the effect of changing economic
conditions in the People's Republic of
China, variations in cash flow, reliance on collaborative
retail partners and on new product development, variations in new
product development, risks associated with rapid technological
change, and the potential of introduced or undetected flaws and
defects in products. Readers are referred to the reports and
documents filed from time to time by the Company with the
Securities and Exchange Commission for a discussion of these and
other important risk factors that could cause actual results to
differ from those discussed in forward-looking statements. Other
than as required under the securities laws, the Company does not
assume a duty to update these forward-looking statements.
Investor Relations Contact:
Steve Liu
steve.liu@jojodrugstores.com
Frank Zhao
Chief Financial Officer
86-571-88077108
frank.zhao@jojodrugstores.com
View original
content:http://www.prnewswire.com/news-releases/china-jo-jo-adds-seven-new-retail-drugstores-in-hangzhou-300566487.html
SOURCE China Jo-Jo Drugstores, Inc.